N-Arachidonoyl Dopamine (NADA)

The endocannabinoid that is also a vanilloid. NADA couples anandamide's fatty tail to dopamine's head — activating cannabinoid receptors and the capsaicin TRPV1 channel at once.

Neurotransmitter Class
Endocannabinoid (amidelinked conjugate)
Receptors
CB1, TRPV1
Release Sites
Striatum, hippocampus, dorsal root ganglia
Clearance
FAAH-class hydrolysis
Net Effect
Cannabinoid and vanilloid activation — pain biology

Synthesis & Release

NADA is an amide of arachidonic acid with dopamine — a molecular chimera of two signaling systems, dopamine and endocannabinoid chemistry fused in one molecule. Found in striatum and sensory neurons at nanomolar levels, it rises with cellular activity and acts as one of the endovanilloids — the body's own capsaicin-like ligands, sensing heat and inflammation at the peripheral terminal. Its dual activation profile — potent TRPV1 opening plus CB1 agonism — placed it at the pain-inflammation interface, where desensitization therapies also act.

Receptor Actions

Physiological Role

Interactions

Clinical Relevance

Sources